Sharemaestro Newsreel

Molina Healthcare, Inc $MOH Stake Lifted by Aurora Investment Managers LLC.

Aurora Investment Managers LLC significantly increased its stake in Molina Healthcare, Inc. (NYSE:MOH) by 118.9% in the second quarter, making it their 4th largest position. Other institutional investors also adjusted their holdings. Molina Healthcare reported strong earnings in the last quarter, surpassing analyst estimates, …

UnitedHealth Group Inc (UNH) CEO Patrick Conway Sells 500 Shares

Patrick Conway, CEO of Optum (a UnitedHealth Group subsidiary), sold 500 shares of UnitedHealth Group Inc (UNH) on August 5, 2026, for approximately $205,000. This sale is part of a broader trend of insider selling at UNH over the past year, with no insider …

Aurora Investment Managers LLC. Invests $7.50 Million in UnitedHealth Group Incorporated $UNH

Aurora Investment Managers LLC. has acquired a new stake of 18,038 shares in UnitedHealth Group (NYSE:UNH), valued at approximately $7.5 million, making it their seventh-largest holding. The healthcare conglomerate has a "Moderate Buy" consensus rating from analysts with a $455.92 price target, and recently …

Assenagon Asset Management S.A. Buys 184,595 Shares of Elevance Health, Inc. $ELV

Assenagon Asset Management S.A. significantly increased its stake in Elevance Health, Inc. (NYSE:ELV) by 160.8% in the second quarter, acquiring an additional 184,595 shares. Other institutional investors also adjusted their holdings in ELV, with notable increases from Wellington Management Group LLP and Price T …

Progyny (PGNY) Stock Looks Fairly Priced With Limited Margin Of Safety

Insurers see positive results in managing health costs in Q2

The health insurance industry, after a challenging 2025, has shown surprising improvements in Q2 2026, with UnitedHealth Group and CVS Health leading in profitability. While Medicare Advantage costs are stabilizing, insurers face ongoing challenges in Medicaid due to upcoming work requirements and continued turbulence …

Progyny (PGNY) Stock Sinks As Guidance Jitters Clash With Margin Strength

UnitedHealth Group: what the health insurance giant does

UnitedHealth Group is the largest health insurer in the U.S. by revenue, operating through two main divisions: UnitedHealthcare for insurance and Optum for health services. Optum, which includes pharmacy care, data analytics, and physician practice management, is the faster-growing segment. The company's significant scale …

UnitedHealth Group (NYSE:UNH) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen has upgraded UnitedHealth Group (NYSE:UNH) from a "hold" to a "buy" rating, contributing to a generally positive analyst outlook that rates the stock as a "Moderate Buy" with an average price target of $455.92. The company recently exceeded earnings estimates, reporting …

DaVita Inc. (DVA) Stock Forecasts

Morningstar analyst Julie Utterback reports on DaVita Inc. (DVA), a major dialysis service provider, stating that the company's shares fell after management maintained its 2026 outlook. The report highlights DaVita's significant market share in the U.S. dialysis sector and its large patient base, primarily …

Oscar Health (OSCR) Stock Jumps As Margins Power A Profit Breakthrough

Healthcare giant slashes key consultation fee to beat rivals

CVS Health (CVS) is targeting the earliest point in a customer's weight-loss drug decision: the first consultation. On Aug. 5, the company dropped the cash price of a MinuteClinic online weight-loss visit to $29, with no membership and no monthly fee. That is the …

Elevance Health (ELV) Stock Looks Below Fair Value But Its 37% Run Tests That

Oscar Health (NYSE:OSCR) Stock Price Expected to Rise, UBS Group Analyst Says

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC

Pomerantz LLP is investigating potential securities fraud claims against Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of "accounting irregularities." The whistleblower complaint suggests the company artificially inflated its financial results, including Adjusted EBITDA, by misclassifying operating expenses as capital expenditures. This …

Humana (HUM) Is Up 5.8% After Cutting 2026 EPS Outlook Amid Strong Q2 And Buybacks

In late July 2026, Humana reported higher second-quarter revenue of US$40,867 million and net income of US$694 million, while also confirming completion of a US$276.13 million share repurchase program initiated in February 2024 and announcing two new board appointments, Paul Smith and Frederick Crawford. …

Molina Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains

Molina Healthcare Inc. (MOH) stock advanced 2.38% on Friday, closing at $196.45, despite the S&P 500 and Dow Jones Industrial Average also seeing gains. The stock underperformed its competitors and closed 19.78% below its 52-week high of $244.89, achieved on July 14th.

UNH Leads Its Peer Group. You Pay For That

UnitedHealth Group (UNH) is the leading company in the health insurance sector, boasting superior operating margins and revenue growth compared to its peers like Cigna. However, this premium performance comes with a high valuation, as UNH trades at a significantly higher P/E ratio. Investors …

Progyny, Inc. Stock 12‑Month Price Target Cut to $33.82, Implies 12% Upside

Progyny, Inc.'s average stock price target has been reduced to $33.82 from $34 by 11 analysts, with individual forecasts ranging from $27 to $40 per share. This updated target suggests a potential 12% upside based on the Aug. 6 closing price. The consensus rating …

Progyny, Inc. 2026: Revenue $350.51M, EPS $0.34— 10-Q Summary

Progyny, Inc. reported strong second-quarter 2026 results, with revenue reaching $350.51 million and diluted EPS of $0.34, showcasing modest top-line growth and significant profitability improvement year-over-year. The company expanded its client base to over 600, covering approximately 7.2 million lives, and saw improved gross …

Progyny Posts Record Q2 Results, Expands Client Base

Progyny reported record second-quarter 2026 results with revenue of $350.5 million, up 5.3% year-over-year, and a 13% increase in gross profit to $89.3 million, despite losing a large client. The company also saw net income rise to $28.1 million and adjusted EBITDA to $62.1 …

Leading Women-Run Companies Shaping the Future of Business

An updated edition of the June 17, 2026 article. Corporate leadership is evolving as more women assume top executive roles at publicly traded companies. This transition is increasingly backed by strong business performance, with many women-led organizations delivering innovation, operational excellence and consistent shareholder …

Why Progyny (PGNY) Shares Are Sliding Today

Progyny's shares dropped by 4.5% after the company issued a weaker-than-expected forecast for the upcoming quarter and lowered its full-year revenue and EBITDA guidance, despite beating second-quarter earnings estimates. This disappointing outlook overshadowed strong Q2 results and previous analyst upgrades, leading to a significant …

Humana Inc. stock outperforms competitors on strong trading day

Humana Inc. (HUM) shares rose by 4.84% to $385.00 on Friday, marking its third consecutive day of gains. This performance outpaced the broader market, with the S&P 500 Index (SPX) increasing by 0.62% and the Dow Jones Industrial Average (DJIA) rising by 0.28%. The …

Why Progyny Stock Plunged, Then Gradually Recovered Today

Progyny's stock initially dropped by 6% after its second-quarter earnings report, despite sales rising 5% and adjusted earnings per share increasing by 15%, both exceeding Wall Street expectations. The market reacted negatively to management's conservative Q3 revenue growth guidance of 7% to 11%. However, …

CVS pharmacy workers in Rhode Island stage walkout over staffing levels

CVS pharmacy workers in Rhode Island have staged a walkout due to staffing levels and burnout, accusing CVS Health Corp. of bad-faith bargaining. This action occurs as CVS plans to utilize pharmacists for its new direct-to-consumer GLP-1 program, adding to their workload. The company …

State Street (UNH holder) discloses 45.7M UnitedHealth Group shares in 13G

State Street Corporation has disclosed a significant passive investment in UnitedHealth Group Inc. via a Schedule 13G filing. The firm beneficially owns 45,684,412 shares, representing a 5% stake in the company. These shares are held with shared voting and dispositive power across various State …

Progyny CEO’s Aug. 11 Boston session will have a live audiocast

Progyny, Inc. (Nasdaq: PGNY) announced that its CEO, Pete Anevski, will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA, on Tuesday, August 11, 2026, at 3:30 p.m. ET. Live audiocasts and replays of the webcasted session will be accessible via …

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny, Inc. announced that its CEO, Pete Anevski, will present at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 3:30 p.m. ET. The presentation will be accessible via a live audiocast and replay on Progyny’s investor relations website. Progyny …

Cigna Group (NYSE: CI) EVP sells 19,436 shares after option exercise

Cigna Group's EVP, Nicole S. Jones, exercised 15,346 employee stock options and subsequently sold 19,436 common shares on August 4-5, 2026. These transactions, valued at approximately $5.37 million, were conducted under a pre-adopted Rule 10b5-1 trading plan. After the sales, Jones retains 28,557 direct …

Higher Q2 profit and share buybacks at Progyny (NASDAQ: PGNY)

Pacer Advisors Inc. Sells 17,053 Shares of Cigna Group $CI

Pacer Advisors Inc. significantly reduced its stake in Cigna Group (NYSE:CI) during the first quarter, selling 17,053 shares, which represents a 56.4% decrease. Despite this, institutional investors collectively own a substantial 86.99% of Cigna's stock, and Wall Street analysts generally maintain a "Moderate Buy" …

Annexon, Inc. Reports Early Clinical Responses in First U.S. and European Patient Cohort of GBS FORWARD Study with Tanruprubart

Annexon, Inc. announced early positive results from the first ten U.S. and European patients in its GBS FORWARD study of tanruprubart. The study showed rapid and clinically meaningful improvements in strength and reduced disability within days for patients with Guillain-Barré syndrome (GBS), a life-threatening …

Progyny, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PGNY) 2026-08-07

Progyny, Inc. has published its Q2 2026 earnings call presentation. The company reported EPS of $0.55, beating estimates by $0.03, and revenue of $350.51 million, surpassing expectations by $1.86 million, representing a 5.30% year-over-year increase. This article provides access to the slide deck presented …

Roman DBDR Acquisition II : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

Roman DBDR Acquisition Corp. II, a blank check company, filed its quarterly report for the quarter ending June 30, 2026 (Form 10-Q). The report details the company's financial condition, results of operations, and ongoing efforts to complete a business combination, specifically with ThomasLloyd. The …

Centene Corp (CNC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Centene Corp (CNC) has an earnings forecast score of 6.87, ranking 48th in the Healthcare Providers & Services industry, with an average price target of $40.00. Analysts' ratings show a majority "Hold" signal based on 23 analysts. The company's expected revenue for the next …